Bioethics News

Right-to-Die Group Comes Up with New, Cheaper Medication

April 5, 2016

(ABC News) – Right-to-die advocates in Washington state have created a cheaper alternative mixture of medications to help terminally ill patients legally end their lives after a drug company abruptly hiked the price of a drug commonly used for the purpose. Doctors with the End of Life Washington advocacy group concocted the alternative for about $500, after Valeant Pharmaceuticals International of Quebec acquired the drug and jacked up the price to about $3,000, The Seattle Times reported.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.